AstraZeneca's Ajam Gautam spoke at last year's BioPharma Mexico on the subject of innovative R&D models for emerging markets. 
We were glad to have Ajay Gautam, Executive Director and Head of Emerging Markets R&D at AstraZeneca, present at last year’s BioPharma Mexico. Enclosed are his presentation slides from the event, where he addressed innovative R&D models for emerging markets.
During his keynote presentation, Ajay discussed:
- Federal budget, regulation, reimbursement infrastructure and other criteria
- Comparing emerging market models based on above criteria: Brazil, Russia, Israel, China and India
- The role of local pharma in encouraging investment